1. Pink Sheet
  2. >>Geography
  3. >>Europe

EU Clarifies Interplay Between CTR And GDPR

 
• By Vibha Sharma

A Q&A document from the European Commission elaborates on alternative legal bases, other than informed consent, for processing clinical trial data under the General Data Protection Regulation.

GDPR
EU Document Gives Clinical Trial Researchers More Clarity On GDPR • Source: Shutterstock

The European Commission's much-awaited question-and-answer document on the interplay between the Clinical Trial Regulation and the General Data Protection Regulation clarifies that informed consent obtained under both these legislative instruments serves different purposes.

Informed consent under the CTR must not be confused with consent as a legal ground for processing personal data under...

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Pink Sheet for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from Europe

More from Geography

EMA Poised To Decide On Fate Of Lilly’s Kisunla And PharmaMar’s Aplidin In EU

 
• By Vibha Sharma

Eli Lilly and PharmaMar were set to make their case before the European Medicines Agency this week as part of re-examination procedures for their respective drugs Kisunla and Aplidin.

After Sarepta Reversed Course On Elevidys, Could An Adcomm Be Next?

 
• By Derrick Gingery and Mandy Jackson

One option for the FDA going forward could be holding an advisory committee meeting on its safety concerns after Sarepta agreed to stop all shipments of its DMD gene therapy.

Advocates Want New Bipartisan PBM Reform Package To Stand Alone

 
• By Leslie Small

A new PBM reform package has familiar provisions, but stakeholders want it to move as a stand-alone bill, rather than as part of a larger legislative vehicle.